Work Package 9 Context

Work Package leader : Inserm Transfert

Communication, Dissemination and Innovation Management


TheraLymph is organizing a well-targeted communication and dissemination effort to ensure a maximum impact of the project and release the full exploitation potential of results. A comprehensive dissemination strategy is of great importance in order to inform key stakeholders (regulatory agencies, policy makers, industry, associations, the scientific community) of the research findings. All partners are involved in the development of the therapy to cure secondary lynphedema, and deliver results likely to be exploited.

To successfully disseminate our project results and maximise the impact of the project, we strongly believe that reproducibility in medical research is of primordial importance. Therefore, efforts are deployed to ensure complete transparency and guarantee that the research community will be able to reproduce our findings. We address the crucial issue of data management by building a data governance strategy that will aim for data quality and rigorous tracking of analyses, and offering a data sharing tool for the research community.

Our communication and dissemination strategy is built around 3 distinct phases:

The first phase (starting M1) will be devoted to raising awareness about the project objectives and expected outcomes. In this context it will be important to build a project identity: a project logo, a brochure and a dedicatedproject website will help raising the project’s profile and communicating to stakeholders and the general public.

In the second phase (starting M12), the consortium will engage with key stakeholders (association for lymphedema patients, European society of lymphology, …) that can directly benefit from the project results. This will include mapping key stakeholders and identify opportunities to make contact with them such as events, conferences organized at local, national, EU and international level.

The third phase (starting M48) involves a well-focused dissemination strategy of the project outcomes to those key stakeholders in order to foster change in the management of lymphedema for the patients and the introduction of new research paradigms in the comprehension of lymphedema physiopathology.

The THERALYMPH initial dissemination and communication plan will be maintained and continuously updated over the course of the project to account for opportunities and project developments.

We are determined to find a treatment.